GB Sciences (GBLX) News Today Add Compare Share Share Headlines Stock AnalysisChartFinancialsSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period GB Sciences Inc (GBLX)August 23, 2024 | investing.comParis Olympics LIVE: Imane Khelif breaks down, Team GB's medal rush, Djokovic vs Alcaraz updatesAugust 5, 2024 | mirror.co.uk'Shorten looks for silver lining as Team GB pipped to gold'August 3, 2024 | bbc.co.ukWashU study reveals key mechanisms of biological clocksJuly 25, 2024 | msn.comGB News posts £42m loss but grows online audienceMarch 12, 2024 | bbc.comGb Sciences’ Novel Parkinson’s Disease Medication is Featured on Worldwide Business with kathy ireland(R)December 14, 2023 | finance.yahoo.comTeam GB News: Medals and Schedule at Winter OlympicsNovember 2, 2023 | dailymail.co.ukDan Wootton's replacement on GB News revealed as he's suspended over Laurence Fox rantOctober 8, 2023 | mirror.co.ukGB News boss explains why Dan Wootton is still on air amid allegations against presenterOctober 6, 2023 | mirror.co.ukGB News suspends third presenter for supporting Dan Wootton in Laurence Fox rowOctober 3, 2023 | mirror.co.ukGB News - Updates on the British television news channelOctober 2, 2023 | dailymail.co.ukGb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of LethbridgeJuly 11, 2023 | finance.yahoo.comINSIGHT-Lab crunch: British science has nowhere to goJune 20, 2023 | reuters.comGBLX - GB Sciences, Inc.May 27, 2023 | finance.yahoo.comGB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in ChinaMarch 20, 2023 | finance.yahoo.comSuccessful 2022 Milestones Support Value of Gb Sciences' AI-Enabled Drug Discovery PlatformMarch 7, 2023 | finance.yahoo.comGB Sciences Stock (OTC:GBLX), Quotes and News SummaryFebruary 18, 2023 | benzinga.comGb Sciences Identifies Novel Cannabis-Inspired Mixtures That Could Treat Viral InfectionsDecember 26, 2022 | benzinga.comGb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based FormulationsDecember 12, 2022 | finance.yahoo.comCannabis Terpenes Reduce Inflammation, Says Gb Sciences StudyNovember 1, 2022 | msn.comGb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis IngredientsNovember 1, 2022 | finance.yahoo.comTODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic SummitOctober 27, 2022 | finance.yahoo.comGb Sciences' Plant-based Formulations Designed to Treat Anxiety Achieve Statistical Significance in Animal StudyOctober 24, 2022 | finance.yahoo.comTODAY: Gb Sciences' President Demonstrates Effectiveness of Simplified Therapeutic Mixtures Inspired by Cannabis Plant Extracts at Canna Pharma 2022 ConferenceOctober 13, 2022 | finance.yahoo.comNew Study Shows Promising Results In Treatment Of Parkinson's Disease With CannabinoidsOctober 10, 2022 | msn.comGb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson's DiseaseOctober 10, 2022 | finance.yahoo.comTODAY: Gb Sciences Describes Drug Development Progress in Pharma's Almanac Journal ArticleSeptember 6, 2022 | finance.yahoo.comGB Sciences, Inc. (GBLX)August 9, 2022 | ca.finance.yahoo.comGb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform-PhAROS(TM)July 20, 2022 | stockhouse.comGb Sciences is Leading Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™July 19, 2022 | finance.yahoo.comGb Sciences Leads Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform—PhAROS™July 18, 2022 | finance.yahoo.comTODAY: Gb Sciences' President and Chief Science Officer Presents Keynote Address on Cannabinoid-Containing Formulations for Parkinson's Disease at 2022 NeuroForum SummitMay 23, 2022 | finance.yahoo.comTODAY: Gb Sciences Showcases Its PhAROS(TM) Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform SummitMay 12, 2022 | stockhouse.comTODAY: Gb Sciences Showcases Its PhAROS™ Drug Discovery Platform at the 2nd ALCOR Drug Discovery Platform SummitMay 12, 2022 | finance.yahoo.comTODAY: Gb Sciences' Novel Plant-Inspired Pain Medications Featured at SMi's 22nd Annual Pain Therapeutics ConferenceMay 5, 2022 | finance.yahoo.comFHI Clinical to Write Clinical Trial Protocol for Development of Gb Sciences' COVID-19-Related, Anti-Inflammatory TherapiesMay 2, 2022 | finance.yahoo.comGb Sciences To Begin Dosage Study For Cannabinoid-Containing Drug For Treatment Of Parkinson's DiseaseApril 17, 2022 | msn.comGb Sciences to Begin Dosage Study for Its Novel Parkinson's Disease Formulations at the University of LethbridgeApril 12, 2022 | finance.yahoo.comGb Sciences' Nanoparticle Encapsulation Technology Improves the Efficacy of Terpenes for Use in Our Chronic Pain Formulations as Demonstrated in New Research ArticleMarch 29, 2022 | finance.yahoo.comUPDATE: Gb Sciences Issues Shareholder LetterMarch 16, 2022 | finance.yahoo.comGb Sciences Issues Summary Shareholder LetterMarch 15, 2022 | finance.yahoo.comGb Sciences gets US patent for cannabinoid-containing mixture to treat heart diseaseMarch 1, 2022 | seekingalpha.comGb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary CystitisMarch 1, 2022 | finance.yahoo.comNot So Fast With The Cannabis-COVID Treatment: Gb Sciences And Michigan State U Researchers ClarifyFebruary 1, 2022 | msn.comGb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus TreatmentFebruary 1, 2022 | finance.yahoo.comGb Sciences Leaves Cannabis Cultivation With $8M Sale Of Las Vegas Facility, Enters BioPharma IndustryJanuary 11, 2022 | msn.comGb Sciences Completes $8 Million Sale of Las Vegas Cannabis FacilityJanuary 11, 2022 | finance.yahoo.comGb Sciences Targets COVID-19 Treatment as Omicron Variant ArrivesDecember 6, 2021 | finance.yahoo.comGb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and AnxietyNovember 1, 2021 | finance.yahoo.comGb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndrome Therapies Designed to Suppress COVID-Related HyperinflammationSeptember 14, 2021 | finance.yahoo.com Get GB Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GBLX and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin GBLX Media Mentions By Week GBLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GBLX News Sentiment▼0.000.47▲Average Medical News Sentiment GBLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GBLX Articles This Week▼00▲GBLX Articles Average Week Get GB Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GBLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Acquired Sales News American Cannabis News AmeriCann News Cannabis Sativa News FutureLand News Marijuana Company of America News Medical Marijuana News WEED News Zoned Properties News ZZLL Information Technology News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GBLX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GB Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GB Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GBLX with Qtrade Free GBLX Stock Alerts